newsfilter
← Latest News
Business Wire·

Revvity's EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing

The IDS i20 platform offers fully automated processing of specialty assays in endocrinology, allergy, autoimmune and infectious diseases, Alzheimer's disease and therapeutic drug monitoring Revvity, Inc. (NYSE:RVTY),